Cardiovascular diseases are a major cause of death around the world underlining the importance of efficient treatments including novel medication. In vitro models of cardiac tissues are highly desired for monitoring electrophysiological response to screen pharmaceutical compounds at an early stage. Here, we report a platinum based 3D pillar electrode platform with cell growth guiding channel, which allows integrated, continuous electrical stimulation and recording of the cardiac tissues. This platform was successfully used to culture beating cardiomyocytes over weeks. The Pt-PDMS pillar electrode showed an impedance of 2.5 ± 0.3 kΩ at 10 Hz that is stable for using in cell cultures at 37 °C. Electrically pacing the cells improved maturation...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
The emerging heart-on-a-chip platforms are promising approaches to establish cardiac cell/tissue mod...
Cardiotoxicity is a major cause of drug failure at the late stages of clinical trials and it is link...
Cardiovascular diseases are a major cause of death around the world underlining the importance of ef...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Heart disease and heart failure are prevalent issues resulting in thousands of deaths every year. Un...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
The emerging heart-on-a-chip platforms are promising approaches to establish cardiac cell/tissue mod...
Cardiotoxicity is a major cause of drug failure at the late stages of clinical trials and it is link...
Cardiovascular diseases are a major cause of death around the world underlining the importance of ef...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
Heart disease and heart failure are prevalent issues resulting in thousands of deaths every year. Un...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
Current platforms for in vitro drug development utilize confluent, unorganized monolayers of heart c...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
The emerging heart-on-a-chip platforms are promising approaches to establish cardiac cell/tissue mod...
Cardiotoxicity is a major cause of drug failure at the late stages of clinical trials and it is link...